Global Information
회사소개 | 문의 | 위시리스트

세계의 식물 유래 백신 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년)

Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

리서치사 Coherent Market Insights
발행일 2018년 12월 상품 코드 769555
페이지 정보 영문
가격
US $ 4,500 ₩ 5,315,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,269,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,813,000 PPT Turned PDF (Enterprise User License)


세계의 식물 유래 백신 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년) Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
발행일 : 2018년 12월 페이지 정보 : 영문

식물은 신흥 경제국의 백신 대규모 생산에 있어서 비용 효율적이고, 안전하고, 효과적인 플랫폼입니다. 식물성 백신 시장의 주요 기업은 감염증 치료에 사용되는 식물 유래 백신의 연구 개발에 나서고 있습니다. 식물 유래 백신은 대량 생산이 가능하고 효율이 높으며, 기존 백신에 비해 낮은 비용으로 제조할 수 있습니다.

세계의 식물 유래 백신(Plant-based Vaccines) 시장을 조사했으며, 시장 개요, 백신 종류·원료·용도·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 개요

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 정보 : 백신 종류별
    • 시장 정보 : 원료별
    • 시장 정보 : 용도별
    • 시장 정보 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 시장 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 개발 동향
  • 역학
  • 식물 유래 백신 제조 관련 기술
  • 식물 유래 백신 생산 : 시나리오
  • 임상시험에서의 식물 유래 의약품
  • 정부 정책
  • 규제 시나리오

제4장 세계의 식물 유래 백신 시장 : 백신 종류별

  • 서론
  • 박테리아 백신
  • 바이러스 백신
  • 기생충 백신
  • 기타

제5장 세계의 식물 유래 백신 시장 : 원료별

  • 서론
  • 잎담배
  • 옥수수
  • 감자
  • 기타

제6장 세계의 식물 유래 백신 시장 : 용도별

  • 서론
  • 인플루엔자
  • 지카바이러스병
  • 에볼라바이러스병
  • 가금 질병
  • 기타

제7장 세계의 식물 유래 백신 시장 : 지역별

  • 서론
  • 미국
  • 캐나다
  • 유럽
  • 라틴아메리카
  • 아시아태평양
  • 중동
  • 아프리카

제8장 경쟁 상황

  • 히트맵 분석
  • 기업 개요
    • Medicago, Inc.
    • iBio, Inc.
    • Icon Genetics- GmbH

제9장 애널리스트의 견해

제10장 부록

KSM 19.02.08

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Plants are a cost-effective, safe, and efficacious platform for large-scale production of vaccine in emerging economies and have the potential via oral administration to elicit a mucosal immune response. Key players in the market are focused on Research & Development (R&D) activities for development of plant-based vaccines for the treatment of infectious diseases. This is owing to the ability of plant-based vaccines to be mass produced, with higher efficiency, while maintaining lower cost compared to conventional vaccines.

Furthermore, increasing prevalence of infectious diseases is expected to drive growth of the plant-based vaccines market. For instance, according to World Health Organization (WHO) December 2017 estimate, a seasonal influenza may result in 290,000- 650,000 deaths each year owing to respiratory diseases alone.

Plants as a vaccine source have the ability to generate complex recombinant proteins with desired structures, while maintaining biological functions and offering greater immune-specificity. Plants can be used as potential delivery system for oral vaccines. These factors propel demand for plant-based vaccines. Moreover, successful completion of ongoing clinical trials studies in the future, is expected to offer lucrative opportunity to manufacturers thus, driving growth of the plant-based vaccines market. For instance, according to clinicalTrials: September 2015 update, clinical study evaluating a safety, tolerability and immunogenicity of a plant-made seasonal Quadrivalent VLP influenza vaccine in adults is currently in phase II clinical stage.

Market Dynamics

Higher efficiency of plant-based vaccines over conventional vaccines and R&D activities and clinical trials for the development plant-based are some of the factors expected to boost growth of the market. Plant-based vaccines against HIV have gained significant traction of researchers, since AIDS has evolved as an alarming health problem, which is increasing economic burden of African countries and several emerging economies. According to the The Joint United Nations Programme on HIV/AIDS (UNAIDS); in 2017, Eastern Europe, Central Asia, the Middle East and North Africa accounted for 95% of new HIV infections. Easy production, oral administration of plant-based vaccines, and absence of purification needs offer great advantage in designing plant-based viral vaccines.

Oral vaccines using plant-based formulations are considered as an alternative or may supplement for standard injection vaccines in the Hepatitis B (HBV) treatment, owing to low-cost production and easy vaccination. However, low efficiency and oral-tolerance are the main barrier in the production of plant-based anti-HBV vaccines. Moreover, according to a report published in the International Journal of Molecular Sciences, January 2013, in order to increase the efficiency of HBV antigen expression, intravenous injection of vaccine is required, as plant-produced purified HBV antigens are highly immunogenic when injected.

Key features of the study:

  • This report provides in-depth analysis of the global plant-based vaccines market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2020 - 2026), considering 2021, as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launch or approval, ongoing research and development activities, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global plant-based vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include, Medicago, Inc., iBio, Inc., and Icon Genetics- GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics.
  • The global plant-based vaccines market report caters to various stakeholders in this industry including investors, researchers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global plant-based vaccines market.

Detailed Segmentation:

  • Global Plant-based Vaccines Market, By Vaccine Type:
    • Bacterial Vaccines
    • Viral Vaccines
    • Parasite Vaccines
    • Others Vaccines
  • Global Plant-based Vaccines Market, By Source:
    • Tobacco Plant
    • Maize
    • Potato
    • Others Sources
  • Global Plant-based Vaccines Market, By Application:
    • Influenza
    • Zika Virus Disease
    • Ebola Virus Disease
    • Poultry Diseases
    • Others Applications
  • Global Plant-based Vaccines Market, By Geography:
    • U.S.
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Canada
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Europe
      • By Vaccine Type:
      • Bacterial Vaccines
      • Viral Vaccines
      • Parasite Vaccines
      • Others Vaccines
      • By Source:
      • Tobacco Plant
      • Maize
      • Potato
      • Others Sources
      • By Application:
      • Influenza
      • Zika Virus Disease
      • Ebola Virus Disease
      • Poultry Diseases
      • Others Applications
    • Latin America
      • Regional Trends
    • Asia Pacific
      • Regional Trends
    • Middle East
      • Regional Trends
    • Africa
      • Regional Trends
  • Company Profiles
    • Medicago, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Key Strategies
    • iBio, Inc.
    • Icon Genetics- GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Technologies Involved in Plant-based Vaccines Production
  • Plant-based Vaccine Production: Scenario
  • Plant-derived Pharmaceuticals in Clinical Trials
  • Government Initiatives
  • Regulatory Scenario

4. Global Plant-based Vaccines Market, By Vaccine Type, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Bacterial Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Viral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Parasite Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

5. Global Plant-based Vaccines Market, By Source, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Tobacco Plant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Maize
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Potato
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

6. Global Plant-based Vaccines Market, By Application, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, 2021 - 2026
    • Segment Trends
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Zika Virus Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Ebola Virus Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Poultry Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2026, (US$ Million)

7. Global Plant-based Vaccines Market, By Region, 2020 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2021 - 2026
  • U.S.
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Canada
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Source, 2020 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2020 - 2026, (US$ Million)
  • Latin America
    • Regional Trends
  • Asia Pacific
    • Regional Trends
  • Middle East
    • Regional Trends
  • Africa
    • Regional Trends

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medicago, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • iBio, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Icon Genetics- GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies

9. Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q